Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of January 5, 2025 • 6:00 PM ET

Date/Time Source News Release
12/10/2024 08:00 AM EST GlobeNewswire INmune Bio Inc. Completes Repayment of Silicon Valley Bank Debt
12/04/2024 09:00 AM EST Business Wire OmniScience Inc. and INmune Bio Inc. Partner to Accelerate a Phase 2 Alzheimer's Trial with Vivo, a Novel genAI Clinical Trial Control Tower
11/13/2024 09:00 AM EST GlobeNewswire INmune Bio Inc. Announces Final Enrollment of 208 Patients in Phase 2 Trial in Early Alzheimer's Disease
10/31/2024 04:05 PM EDT GlobeNewswire INmune Bio Inc. Announces Third Quarter 2024 Results and Provides Business Update
10/28/2024 08:00 AM EDT GlobeNewswire INmune Bio Inc. to Host Webinar on Cognitive Testing Using EMACC and CDR-SB
10/24/2024 03:03 PM EDT GlobeNewswire INmune Bio Inc. Announces Publication in Cell Reports Demonstrating XPro(TM) Promotes Remyelination
10/24/2024 09:30 AM EDT GlobeNewswire INmune Bio Inc. to Report Third Quarter 2024 Financial Results and Provide Corporate Update on October 31, 2024
10/11/2024 08:30 AM EDT GlobeNewswire INmune Bio Inc. to Participate in the Maxim Healthcare Virtual Summit
09/30/2024 08:00 AM EDT GlobeNewswire INmune Bio Inc. Completes Enrollment for Phase 2 Trial in Early Alzheimer's Disease
09/26/2024 08:00 AM EDT GlobeNewswire INKmune(TM) Demonstrates Excellent Safety and Increased NK-Cell Activity in First Dosing Cohort
Page

Additional News

As of January 5, 2025 • 6:00 PM ET

Date/Time Source News Release
01/02/2025 08:52 AM EST SeekingAlpha INmune Bio: Phase 2 Trial In Alzheimer's Disease Is My Highest Risk-Reward Bet Of 2025
12/30/2024 03:20 PM EST SeekingAlpha INmune Bio: XPro Cognitive Readout In Sight, But Mind The Financial Dangers
11/27/2024 04:30 AM EST US Earnings Reports Expected earnings - INmune Bio Inc.
10/31/2024 08:09 PM EDT SeekingAlpha INmune Bio, Inc. (INMB) Q3 2024 Earnings Call Transcript
10/31/2024 04:12 PM EDT SeekingAlpha INmune Bio GAAP EPS of -$0.60 misses by $0.10
10/31/2024 10:00 AM EDT SeekingAlpha Here are the major earnings after the close today
10/30/2024 05:35 PM EDT SeekingAlpha INmune Bio Q3 2024 Earnings Preview
10/18/2024 01:16 PM EDT Stock Traders Daily (INMB) Technical Data
09/30/2024 05:04 AM EDT SeekingAlpha INmune Bio: NK Cell Therapy INKmune For mCRPC Is Another Shot On Goal
09/27/2024 03:37 PM EDT SeekingAlpha Achieve, INmune, Lenz gain on bullish initiations from Raymond James
Page